British Pregnancy Advisory Service v Secretary of State for Health

Factual and Procedural Background

The Claimant, an advisory service specializing in pregnancy matters, brought these proceedings seeking a declaratory judgment regarding the interpretation of section 1 of the Abortion Act 1967. Specifically, the Claimant sought to establish that a pregnancy is "terminated by a registered medical practitioner" when such a practitioner prescribes an abortifacient drug with the intention of terminating the pregnancy, and that the administration of that drug by the pregnant woman herself is not considered "any treatment for the termination of pregnancy" under the Act.

The claim was made under Part 8 of the Civil Procedure Rules 1998, as it concerned statutory construction and a question of law rather than a dispute of fact. The Claimant aimed to clarify the law to allow the piloting and potential adoption of a process known as "early medical abortion" ("EMA"), whereby part of the treatment is self-administered by the woman at home, subject to regulation.

The factual background includes the historical context of abortion methods, the current medical practice for EMA involving two stages of drug administration, and the Claimant's view that existing arrangements are sub-optimal for women. The Secretary of State acknowledged that other countries permit administration of the second-stage drug at home but emphasized the need for piloting and regulation before adopting such a practice in Great Britain.

Legal Issues Presented

1. What is the proper statutory interpretation of the phrase "any treatment for the termination of pregnancy" in section 1(3) of the Abortion Act 1967?
2. Does the concept of "treatment" include the administration of abortifacient drugs by the woman herself at home, or is it limited to actions undertaken within approved medical settings?
3. What is the scope of the Secretary of State's power to approve places for treatment under sections 1(3) and 1(3A) of the Act?
4. How should the Act be construed in light of developments in medical science and statutory amendments since 1967?
5. What are the implications of the interpretation for conscientious objection protections under section 4 of the Act?

Arguments of the Parties

Appellant's Arguments

• The primary concern of Parliament in passing the 1967 Act was to ensure abortions were carried out safely and in proper conditions, which at that time meant hospital settings due to the invasive nature of surgical abortion.
• Medical science has advanced, and early medical abortion (EMA) now involves drugs that can be safely self-administered at home; thus, the Act should be construed to allow part of the treatment (self-administration) outside approved places.
• The term "treatment" should be interpreted as limited to the act of prescribing the abortifacient drug, not including its administration.
• The court should apply an "updating construction" to the statute, reflecting contemporary medical practice and scientific knowledge, consistent with established principles of statutory interpretation.
• The safety of abortion is unaffected by whether the relevant medication is taken in an approved place or at home, satisfying the mischief the Act intended to address.
• The Claimant accepts there may be a lacuna regarding conscientious objection protections but argues this is comparable to gaps recognized in prior case law.

Respondent's Arguments

• The natural and ordinary meaning of "treatment" includes the taking (administration) of the abortifacient drug, not merely its prescription.
• "Treatment" is a broad concept covering all types of treatment for termination, including medical and surgical interventions.
• Section 1(3A) of the Act, introduced in 1990, expressly contemplates treatment consisting primarily of the use of medicines and confirms that the Secretary of State has responsibility for approving places where such treatment may occur.
• The Claimant's interpretation would remove the Secretary of State's statutory role in approving treatment locations, contrary to Parliament's clear intention.
• The Claimant's proposed interpretation would apply to all stages of pregnancy and all abortifacient drugs, including those without established safety profiles for home use.
• The doctrine of the "always speaking" statute does not assist the Claimant because Parliament specifically addressed the location and manner of medical abortion treatment in the 1990 amendment.
• The regulatory regime is not a substitute for the statutory controls and does not provide equivalent safeguards or sanctions.
• Health and social care being devolved matters, while abortion is reserved to Parliament, creates potential inconsistencies if the Claimant's interpretation were accepted.
• Conscientious objection protections under section 4 would be undermined if administration by medical professionals is excluded from the definition of treatment.

Table of Precedents Cited

Court's Reasoning and Analysis

The court undertook a detailed statutory construction exercise focused on the phrase "any treatment for the termination of pregnancy" in section 1(3) of the Abortion Act 1967. It rejected the Claimant's narrow interpretation that "treatment" comprises only the prescription of abortifacient drugs, excluding the administration thereof.

The court emphasized the ordinary and natural meaning of "treatment" in a medical context, which includes "management in the application of remedies" and thus embraces the taking of abortifacient drugs. It noted that if drugs were prescribed but not taken, treatment would not have occurred, underscoring that administration is integral to treatment.

The court relied heavily on the House of Lords decision in Royal College of Nursing, which held that termination is a process carried out under medical supervision involving a team effort, not a single act of prescription. It also noted that Parliament contemplated both surgical and medical methods of abortion in 1967.

The court considered the 1990 amendment (section 1(3A)) as a statutory exposition clarifying that treatment includes the use of medicines and that the Secretary of State has the power to approve places where such treatment may occur. This undermined the Claimant's argument that the home could be considered an approved place without Secretary of State approval.

The court rejected the application of the "always speaking" statute principle to extend the meaning of treatment to permit self-administration at home without approval, given the explicit statutory framework.

Regarding conscientious objection under section 4, the court found that the Claimant’s interpretation would create a lacuna leaving medical professionals unprotected, which Parliament did not intend.

The court also acknowledged the controversial nature of abortion law and the importance of adhering to Parliament’s clear intentions to maintain regulatory oversight and safety standards.

Holding and Implications

The Claimant's claim is dismissed.

The court held that under the Abortion Act 1967, "treatment for the termination of pregnancy" includes both the prescription and administration of abortifacient drugs, and that such treatment must take place in a hospital or other place approved by the Secretary of State. The administration of abortifacient drugs by a pregnant woman at home without such approval does not fall within the lawful scope of treatment under the Act.

This decision maintains the existing statutory framework that places responsibility for approving treatment locations with the Secretary of State and ensures that regulatory safeguards remain in place. No new precedent altering the statutory regime was established beyond the clear application of existing law and principles of statutory interpretation.